Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Jan;93(1):53-60.
doi: 10.1097/MD.0000000000000013.

Urticarial vasculitis in northern Spain: clinical study of 21 cases

Affiliations
Case Reports

Urticarial vasculitis in northern Spain: clinical study of 21 cases

Javier Loricera et al. Medicine (Baltimore). 2014 Jan.

Abstract

Urticarial vasculitis (UV) is a subset of cutaneous vasculitis (CV), characterized clinically by urticarial skin lesions of more than 24 hours' duration and histologically by leukocytoclastic vasculitis. We assessed the frequency, clinical features, treatment, and outcome of a series of patients with UV. We conducted a retrospective study of patients with UV included in a large series of unselected patients with CV from a university hospital. Of 766 patients with CV, UV was diagnosed in 21 (2.7%; 9 male and 12 female patients; median age, 35 yr; range, 1-78 yr; interquartile range, 5-54 yr). Eight of the 21 cases were aged younger than 20 years old. Potential precipitating factors were upper respiratory tract infections and drugs (penicillin) (n = 4; in all cases in patients aged <20 yr), human immunodeficiency virus (HIV) infection (n = 1), and malignancy (n = 1). Besides urticarial lesions, other features such as palpable purpura (n = 7), arthralgia and/or arthritis (n = 13), abdominal pain (n = 2), nephropathy (n = 2), and peripheral neuropathy (n = 1) were observed. Hypocomplementemia (low C4) with low C1q was disclosed in 2 patients. Other abnormal laboratory findings were leukocytosis (n = 7), increased erythrocyte sedimentation rate (n = 6), anemia (n = 4), and antinuclear antibody positivity (n = 2). Treatment included corticosteroids (n = 12), antihistaminic drugs (n = 6), chloroquine (n = 4), nonsteroidal antiinflammatory drugs (n = 3), colchicine (n = 2), and azathioprine (n = 1). After a median follow-up of 10 months (interquartile range, 2-38 mo) recurrences were observed in 4 patients. Apart from 1 patient who died because of an underlying malignancy, the outcome was good with full recovery in the remaining patients. In conclusion, our results indicate that UV is rare but not exceptional. In children UV is often preceded by an upper respiratory tract infection. Urticarial lesions and joint manifestations are the most frequent clinical manifestation. Low complement serum levels are observed in a minority of cases. The prognosis is generally good, but depends on the underlying disease.

PubMed Disclaimer

Conflict of interest statement

*Drs. González-Gay and Blanco share senior authorship.

Financial support and conflicts of interest: This study was supported by grants from “Fondo de Investigaciones Sanitarias” PI12/00193 (Spain). This work was also partially supported by RETICS Programs, RD08/0075 (RIER) and RD12/0009/0013 from “Instituto de Salud Carlos III” (ISCIII) (Spain). The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Typical urticarial lesions in a patient presenting with urticarial vasculitis (A and B; residual purpuric lesions can be observed in B).
FIGURE 2
FIGURE 2
A, Perivascular and interstitial infiltrate of polymorphonuclear neutrophils and eosinophils ( white arrow) with leukocytoclastic venulitis. (Hematoxylin-eosin stain; original magnification × 100.) B, Perivascular eosinophilic infiltrate with fibrin deposits (short white arrow) and karyorrhexis (long white arrow). (Hematoxylin-eosin stain; original magnification × 200.)

References

    1. Alexander JL, Kalaaji AN, Shehan JM, Yokel BK, Pittelkow MR. Plasmapheresis for refractory urticarial vasculitis in a patient with B-cell chronic lymphocytic leukemia. J Drugs Dermatol. 2006;5:534–537. - PubMed
    1. Babajanians A, Chung-Park M, Wisnieski JJ. Recurrent pericarditis and cardiac tamponade in a patient with hypocomplementemic urticarial vasculitis syndrome. J Rheumatol. 1991;18:752. - PubMed
    1. Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis. Int J Dermatol. 1988;27:468–505. - PubMed
    1. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine (Baltimore). 1998;77:403–418. - PubMed
    1. Brewer JD, Davis MDP. Urticarial vasculitis. In: Basow DS, ed. UpToDate website. Waltham, MA: UpToDate; 2013.

Publication types

MeSH terms